Indian breast cancer treatment shows Real-World promise
NCT ID NCT07363434
Summary
This study looked at how well the drug ribociclib worked in real-world settings for 335 Indian women with advanced breast cancer. Researchers analyzed medical records from 18 hospitals to understand how long the treatment kept the cancer from worsening and what side effects patients experienced. The goal was to see how this already-approved treatment performs in everyday clinical practice rather than in a controlled trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.